Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 11, 2023

BUY
$0.14 - $0.24 $17,248 - $29,568
123,200 Added 52.43%
358,200 $75,000
Q1 2023

May 12, 2023

SELL
$0.16 - $0.74 $29,536 - $136,604
-184,600 Reduced 43.99%
235,000 $38,000
Q4 2022

Feb 13, 2023

SELL
$0.46 - $1.21 $115,465 - $303,724
-251,012 Reduced 37.43%
419,600 $233,000
Q3 2022

Nov 14, 2022

SELL
$0.59 - $1.7 $53,425 - $153,938
-90,552 Reduced 11.9%
670,612 $798,000
Q2 2022

Aug 12, 2022

SELL
$0.49 - $1.2 $96,185 - $235,555
-196,296 Reduced 20.5%
761,164 $481,000
Q1 2022

May 13, 2022

BUY
$0.85 - $2.4 $502,405 - $1.42 Million
591,065 Added 161.32%
957,460 $1.09 Million
Q4 2021

Feb 11, 2022

BUY
$1.86 - $3.36 $589,610 - $1.07 Million
316,995 Added 641.69%
366,395 $824,000
Q3 2021

Nov 12, 2021

SELL
$1.52 - $3.82 $1.02 Million - $2.56 Million
-669,967 Reduced 93.13%
49,400 $169,000
Q2 2021

Aug 13, 2021

SELL
$2.66 - $3.47 $1.11 Million - $1.45 Million
-416,700 Reduced 36.68%
719,367 $2.15 Million
Q1 2021

May 13, 2021

SELL
$1.98 - $5.36 $2.14 Million - $5.79 Million
-1,079,907 Reduced 48.73%
1,136,067 $3.67 Million
Q4 2020

Feb 10, 2021

BUY
$1.05 - $2.77 $450,493 - $1.19 Million
429,041 Added 24.01%
2,215,974 $4.7 Million
Q3 2020

Nov 13, 2020

BUY
$0.82 - $1.34 $128,161 - $209,435
156,295 Added 9.58%
1,786,933 $2.09 Million
Q2 2020

Aug 13, 2020

BUY
$0.77 - $1.13 $188,822 - $277,103
245,224 Added 17.7%
1,630,638 $1.48 Million
Q1 2020

May 14, 2020

BUY
$0.69 - $1.52 $87,699 - $193,193
127,101 Added 10.1%
1,385,414 $1.16 Million
Q4 2019

Feb 13, 2020

BUY
$0.88 - $1.29 $120,888 - $177,211
137,373 Added 12.26%
1,258,313 $1.21 Million
Q3 2019

Nov 13, 2019

BUY
$1.03 - $1.75 $122,502 - $208,134
118,934 Added 11.87%
1,120,940 $1.16 Million
Q2 2019

Aug 12, 2019

BUY
$1.43 - $1.87 $158,452 - $207,207
110,806 Added 12.43%
1,002,006 $1.8 Million
Q1 2019

May 14, 2019

BUY
$1.18 - $1.91 $81,774 - $132,363
69,300 Added 8.43%
891,200 $1.68 Million
Q4 2018

Feb 13, 2019

BUY
$1.01 - $2.78 $830,119 - $2.28 Million
821,900 New
821,900 $970,000

Others Institutions Holding INFI

About INFINITY PHARMACEUTICALS, INC.


  • Ticker INFI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 89,277,904
  • Description
  • Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...
More about INFI
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.